HM Payson & Co
- SEC CIK
- 0000928052
- Latest filing
- Jul 17, 2026
AVNS holding history
Avanos Medical, Inc. in every 13F filed by HM Payson & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AVNS overviewAll 13F holders of AVNSFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −1,250−100.0% | Sold out | Holders |
| Q4 2025 | 1,250 | $14.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 1,250 | $14.4K | <0.1% | +1,250 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −48−100.0% | Sold out | Holders |
| Q3 2023 | 48 | $971 | <0.1% | +48 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −3−100.0% | Sold out | Holders |
| Q1 2023 | 3 | $90 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 3 | $81 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 3 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q2 2022 | 3 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q1 2022 | 3 | $0 | 0.0% | −12−80.0% | Reduced | Holders |
| Q4 2021 | 15 | $1.00K | <0.1% | −54−78.3% | Reduced | Holders |
| Q3 2021 | 69 | $2.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 69 | $3.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 69 | $3.00K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.